Multiple acne cream products from well-known brands including La Roche-Posay, Proactiv, and Walgreens have been voluntarily recalled in the U.S. due to possible benzene contamination, a known carcinogen. Overseas buyers sourcing personal-care ingredients or finished formulations should monitor this development closely, as it signals heightened regulatory scrutiny on benzene residues in cosmetics and may affect supply-chain compliance requirements for benzoyl peroxide-based products.
Recall scope and affected products
The U.S. Food and Drug Administration issued a retail-level recall notice on March 11, 2025, covering six products: Walgreens Acne Control Cleanser, Proactiv Skin Smoothing Exfoliator, SLMD Benzoyl Peroxide Acne Lotion, La Roche-Posay Effaclar Duo Dual Action Acne Treatment, and others. The affected lots have expiration dates ranging from April 2025 to March 2026. The recall is limited to removing products from store shelves and online marketplaces; consumers are not required to take action.
Benzene risk and regulatory context
Benzene is classified by the U.S. CDC as a substance that can cause leukemia with long-term high-level exposure. The FDA emphasized that the risk from these products is "very low," even with decades of daily use. However, the recall underscores a broader trend of regulatory attention on benzene contamination in personal-care products, following similar recalls of hair care items by Unilever and others. Importers should review their own quality-control protocols for benzene testing.
Company responses and corrective actions
La Roche-Posay stated that testing revealed "minimal traces" of benzene in one lot of its Effaclar Duo product and that it is removing remaining units to transition to a new formula developed since 2024. Proactiv's maker, Alchemee LLC, is offering refunds or replacements for two lots of Emergency Blemish Relief and one lot of Skin Smoothing Exfoliator. Walgreens confirmed compliance with the recall, citing an "abundance of caution." SLMD did not respond to requests for comment.
What buyers should watch
Overseas buyers of benzoyl peroxide acne treatments or raw materials should verify that their suppliers conduct routine benzene testing and comply with evolving FDA or equivalent international standards. The recall may lead to tighter import controls on personal-care ingredients from U.S. and global sources. Companies distributing these brands outside the U.S. should check if their local regulatory bodies issue similar advisories. Additionally, the transition to reformulated products by La Roche-Posay may create short-term supply gaps.
Source: Read the original report | Published: March 13, 2025